Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PSA | Common Stock | Options Exercise | $458K | +1.67K | +30.06% | $275.12 | 7.21K | Apr 26, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PSA | Stock Option (Right to Buy) | Options Exercise | $0 | -1.67K | -33.32% | $0.00 | 3.33K | Apr 26, 2022 | Common stock | 1.67K | $275.12 | Direct | F2, F3 |
Id | Content |
---|---|
F1 | Includes 542 deferred stock units. |
F2 | Stock Option granted pursuant to the 2016 Equity and Performance-Based Incentive Compensation Plan. Option vests in three (3) equal annual installments beginning one (1) year from the grant date. |
F3 | This option to purchase 5,000 shares of common stock became exercisable as to one-third on April 26, 2022 and becomes exercisable as to one-third on each of April 26, 2023 and 2024. |